SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-24-001796
Filing Date
2024-01-05
Accepted
2024-01-05 16:14:25
Documents
4
Period of Report
2024-01-05

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm242042d1_pre14a.htm PRE 14A 298541
2 GRAPHIC tm242042d1_pre14aimg001.jpg GRAPHIC 4172
3 GRAPHIC tm242042d1_pre14aimg002.jpg GRAPHIC 232497
4 GRAPHIC tm242042d1_pre14aimg003.jpg GRAPHIC 104623
  Complete submission text file 0001104659-24-001796.txt   770161
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37897 | Film No.: 24516392
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)